A nonsense mutation in the cytochrome P450 CYP2D6 gene identified in a Caucasian with an enzyme deficiency

This publication has 20 references indexed in Scilit:

• A missense mutation in exon 6 of the CYP2D6 gene leading to a histidine 324 to proline exchange is associated with the poor metabolizer phenotype of sparteine
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1994
• Identification of a new variant CYP2D6 allele with a single base deletion in exon 3 and its association with the poor metabolizer phenotype
  Human Molecular Genetics, 1994
• Poor metabolisers of nicotine and CYP2D6 polymorphism
  The Lancet, 1994
• Pharmacogenetic Phenotyping and Genotyping
  Clinical Pharmacokinetics, 1994
• Genetic polymorphism of cytochrome P450 CYP2D6 in Zimbabwean population
  Pharmacogenetics, 1993
• Relationship between personality and debrisoquine hydroxylation capacity
  Acta Psychiatrica Scandinavica, 1993
• Metabolic polymorphisms
  Pharmacology & Therapeutics, 1993
• Mutant debrisoquine hydroxylation genes in Parkinson's disease
  The Lancet, 1992
• A tobacco smoke-derived nitrosamine, 4-(methytnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytocbrome P450s including the polymorphic human cytochrome P4502D6
  Carcinogenesis: Integrative Cancer Research, 1991
• Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification
  The Lancet, 1990